Longevity & AgingScientists Identify TRIM21 as a Key Driver of Age-Related Bone Loss
Researchers have identified TRIM21, an E3 ubiquitin ligase, as a critical molecular driver of age-related osteoporosis. In aging bone marrow stromal cells (BMSCs), TRIM21 expression rises — especially in cells primed toward fat production. Elevated TRIM21 tips the cellular decision-making balance away from bone-forming osteoblasts and toward fat-storing adipocytes. The mechanism involves the IL-1β-JNK MAPK signaling pathway activating TRIM21, which then tags the pro-bone protein β-catenin for destruction via K48 ubiquitination. The result is less bone formation, greater marrow fat accumulation, and progressive age-related bone loss. Targeting TRIM21 may offer a new therapeutic avenue for treating osteoporosis and improving bone regeneration in older adults.
